| Market Research A to Z | Company Profiles A to Z | Register | Contact Us |
| +44 (0) 203 086 8600 Call us on |
Pricing and Reimbursement Strategies for Medical Devices
Market |
Healthcare and Medical |
Report Type |
Market Research |
Country |
Global |
Published |
8 February 2012 |
Number of Pages |
150 |
1-3 hours, 24 hour max |
|
Publisher |
Business Insights |
File Format |
In the US, price skimming is the most frequently used strategy in the medical device market, but market segmentation should be used to assess if other strategies, such as penetration pricing, would be more apt in particular sectors.
Within each country regional differences between purchasing and pricing are increasing. Pricing should be determined by examining the requirements of the purchasing institution and regional requirements, but caution should be taken not to undervalue the product and to be aware of the global strategy. It is easier to lower a price than to raise it.
Report Overview
The routes to medical devices being purchased within public healthcare systems vary significantly between countries. The major markets of the US and Europe are examined in this report, analyzing the strategies being used by medical device manufacturers to sell and succeed within them.
Report Scope
- Understand the healthcare structure in the US, Germany, France, Italy, Spain, and the UK.
- Identify the most prominent factors influencing the reimbursement environment globally and on a country-specific basis.
- Gain insight into the reimbursement routes for three product sectors in each country.
- Compare the differences in pricing and market entry strategies that work best in each country.
- Gain recommendations for how pricing and reimbursement strategies should be developed for optimum results.
Reasons To Buy
- What is the nature of the market environment across Europe and in the US?
- How are the reimbursement sectors divided?
- Who pays for medical devices and what are the decision-making processes involved?
- What role do national health frameworks play, and which government bodies have the greatest influence on pricing and reimbursement?
- What is appropriate pricing, and how is the correct balance achieved?
Visitor Comments
|
All posts are pre-moderated and must obey the house rules. |
|
Healthcare and Medical Company Profiles
Find latest Healthcare and Medical Company Profiles with up to date financial, strategic, operational, SWOT analysis and product information for the leading healthcare and medical companies.
Competitor Tracking
Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.
Become an Affiliate
Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?
Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.
Custom Research
Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.
News
Digital pathology market to reach a value of $542 million by 2018
Infectious disease treatments market driven by growth in middle-income to low-income countries
OCT imaging market led by Carl Zeiss and St. Jude Medical
Healthcare decision support market led by McKesson and IBM's Watson
